How to overcome retinal neuropathy: the fight against angiogenesis-related blindness
- PMID: 21052933
- DOI: 10.1007/s12272-010-1007-6
How to overcome retinal neuropathy: the fight against angiogenesis-related blindness
Abstract
The retina consists of neuronal cells of high metabolic activity that are supplied by an abundant vasculature. It is a main theme of ophthalmologic research, because retinopathies are common causes of blindness in all age groups: age-related macular degeneration in the elderly, diabetic retinopathy in the middle aged, and retinopathy of prematurity and retinoblastoma in children. Interestingly, angiogenesis underlies the pathogenesis of all these diseases, and breakdown of the blood-retinal barrier is also thought to play an important role before and throughout the process of new vessel formation. However, so far, most treatments have targeted angiogenesis only, especially vascular endothelial growth factor. Consideration of the restoration of the blood-retinal barrier should be required. In this review, we discuss the clinical manifestation, pathogenesis, and current treatment options for angiogenesis-related blindness. In addition, because of the recent introduction of novel strategies, we describe pathogenesis-based treatment options to treat angiogenesis-related blindness.
Similar articles
-
Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.Eur J Pharmacol. 2009 Aug 1;615(1-3):150-4. doi: 10.1016/j.ejphar.2009.05.015. Epub 2009 May 24. Eur J Pharmacol. 2009. PMID: 19470386
-
Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Verh K Acad Geneeskd Belg. 2005. PMID: 16334858 Review.
-
[Angiogenesis and inhibition of angiogenesis in the eye].Klin Monbl Augenheilkd. 1997 Jun;210(6):341-51. doi: 10.1055/s-2008-1035072. Klin Monbl Augenheilkd. 1997. PMID: 9333658 Review. German.
-
Inhibiting angiogenesis in retinoblastoma.Ophthalmic Res. 2007;39(4):188-90. doi: 10.1159/000103578. Epub 2007 Jun 6. Ophthalmic Res. 2007. PMID: 17556838 Review. No abstract available.
-
Müller cell-derived VEGF is a significant contributor to retinal neovascularization.J Pathol. 2009 Dec;219(4):446-54. doi: 10.1002/path.2611. J Pathol. 2009. PMID: 19768732
Cited by
-
Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors.J Mol Med (Berl). 2014 Oct;92(10):1083-92. doi: 10.1007/s00109-014-1168-8. Epub 2014 May 31. J Mol Med (Berl). 2014. PMID: 24875598
-
Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.Oncotarget. 2017 Jul 11;8(28):45506-45516. doi: 10.18632/oncotarget.17221. Oncotarget. 2017. PMID: 28477014 Free PMC article.
-
Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy.J Lipid Atheroscler. 2020 May;9(2):268-282. doi: 10.12997/jla.2020.9.2.268. Epub 2020 May 18. J Lipid Atheroscler. 2020. PMID: 32821736 Free PMC article. Review.
-
Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells.PLoS One. 2012;7(3):e33456. doi: 10.1371/journal.pone.0033456. Epub 2012 Mar 22. PLoS One. 2012. PMID: 22457763 Free PMC article.
-
The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7426-31. doi: 10.1167/iovs.12-10661. Invest Ophthalmol Vis Sci. 2012. PMID: 23036996 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
